CTCs and Circulating Tumor DNA for the Monitoring of Breast Cancer Patients

In this interview we discuss the use of CTCs and circulating tumor DNA for prognosis and disease monitoring in patients with breast cancer. (Source: CancerNetwork)

from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2nN5IWH
via IFTTT